Lars Ottestad
- Oncology top 2%
- HER2/EGFR in Cancer Research 8
- Cancer-related Molecular Pathways 6
- Bone health and treatments 5
- Cancer Cells and Metastasis 4
- Cancer Research top 5%
- Breast Cancer Treatment Studies 7
- Cancer Genomics and Diagnostics 5
- Genetics top 5%
- Estrogen and related hormone effects 8
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Jürgen GeislerPer Eystein LønningAlwynne TidyIan SmithJohn А. KanisS. AshleyEugène McCloskeySteinar Lundgren
- Cited by
- OncologyCancer ResearchGenetics
- Journals
- British Journal of Cancer (6 papers)Journal of Clinical Oncology (5 papers)Genes Chromosomes and Cancer (3 papers)
- Partner nations
- NorwayUnited StatesFrance
In The Last Decade
Lars Ottestad
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 83
- Oncology 1.2k
- Cancer Research 517
- Genetics 583
- Orthopedics and Sports Medicine 144
- Radiology, Nuclear Medicine and Imaging 371
Countries citing papers authored by Lars Ottestad
This map shows the geographic impact of Lars Ottestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Ottestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Ottestad more than expected).
Fields of papers citing papers by Lars Ottestad
This network shows the impact of papers produced by Lars Ottestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Ottestad. The network helps show where Lars Ottestad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Ottestad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | 2016 | 16 | |
| 3 | 2012 | 12 | |
| 4 | 2006 | 17 | |
| 5 | 2006 | 195 | |
| 6 | 2005 | 7 | |
| 7 | [Breast cancer patients' assessment of waiting time before radiotherapy]. | 2003 | 2 |
| 8 | 2001 | 9 | |
| 9 | 1996 | 288 | |
| 10 | 1993 | 11 | |
| 11 | 1993 | 11 | |
| 12 | 1993 | 143 | |
| 13 | 1992 | 93 | |
| 14 | C-erbB-2 protein and neuroendocrine expression in breast carcinomas. | 1991 | 15 |
| 15 | 1991 | 13 | |
| 16 | 1990 | 89 | |
| 17 | 1990 | 58 | |
| 18 | 1989 | 6 | |
| 19 | 1988 | 6 | |
| 20 | An immunocytochemical method for assaying oestrogen receptors in breast cancers. A comparison with the steroid binding assay. | 1988 | 6 |
About Lars Ottestad
Lars Ottestad is a scholar working on Oncology, Cancer Research and Genetics, having authored 35 papers that have together received 1.7k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (8 papers), HER2/EGFR in Cancer Research (8 papers), Breast Cancer Treatment Studies (7 papers), Cancer-related Molecular Pathways (6 papers), Bone health and treatments (5 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Cells and Metastasis (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (517 citations) and Genetics (583 citations). Lars Ottestad has collaborated with scholars based in Norway, United States and France. Frequent co-authors include Jürgen Geisler, Per Eystein Lønning, Alwynne Tidy, Ian Smith, John А. Kanis, S. Ashley, Eugène McCloskey, Steinar Lundgren, Mitch Dowsett and P. Walton. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Genes Chromosomes and Cancer, Acta Oncologica and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.